ガイドライン

(旧版)エビデンスとコンセンサスを統合した潰瘍性大腸炎の診療ガイドライン ―難治性炎症性腸管障害に関する調査研究班 プロジェクト研究グループ

書誌情報
 
II 潰瘍性大腸炎の診療に関する推奨ステートメントと解説


6.緩解期の潰瘍性大腸炎における維持療法

引用文献

1) Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr 2004;23:161-70.
2) Kornbluth A, Sachar DB. Ulcerative colitis practice guideline in adults (Update): American College of Gastroenterology, Practice Parameters Committee. Am J Gasteroenterol 2004;99:1371-1385.
3) Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004;53(Suppl V):v1-v16.
4) Katz S. Update in medical therapy of ulcerative colitis. J Clin Gastroenterol 2002;34:397-407.
5) Stevens AC. Sulfasalazine and 5-aminosalicylates in the treatement of inflammatory bowel disease. UpToDate 2005, version 13.2.
6) Dickenson RJ, King A, Wight DG, Hunter JO, Neale G. Is continuous sulfasalazine necessary in the management of patients with ulcerative colitis? Results of a preliminary study. Dis Colon Rectum 1985;28:929-30.
7) The mesalamine study group. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. Ann Intern Med 1996;124:204-11.
8) Miner P, Hanauer S, Bobinson M, Schwartz J, Arora S. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. Dig Dis Sci 1995;40:296-304.
9) Mulder CJ, Tytgat GN, Weterman IT, et al. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 1988;95:1449-53.
10) Sunderland L, Roth D, Beck P, et al. Oral 5-aminosalicylic acid for maintaining remission in ulcerative colitis. Cochrane Database Syst Rev Issue 2, 2000.
11) Ardizzone S, Petrillo M, Molteni P, Desideri S, Bianchi, Porro G. Coated oral 5-aminosalicylic acid (Clavesal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study. J Clin Gastroenterol 1995;21:287-9.
12) Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited. A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993;118:540-549.
13) Riley SA, Mani V, Godman MJ, Herd ME, Dutt S, Turnberg LA. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 1988;94:1383-9.
14) Fockens P, Mulder CJ, Tytgat GN, et al. Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. Eur J Gastroenterol Hepatol 1995;7:1025-30.
15) Kane S, Huo D, Magnanti K. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol 2003;1:170-3.
16) Biddle WL, Greenberger NJ, Swan JT, McPhee MS, Miner PB Jr. 5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitiis. Gastroenterology 1988;94:1075-9.
17) Cohen RD, Woseth DM, Thisted RA, Hanauer SB. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000;95:1263-76.
18) Andreoli A, Spinella S, Levenstein S, Prantera C. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Ital J Gastroenterol 1994;25:121-5.
19) d'Albasio G. Pacini F, Camarri E, et al. Combined therapy with 5-aminosalicylic acid and tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. Am J Gastroenterol 1997;92:1143-7.
20) Hawthrone AB, Logan RF, Hawkey CJ, et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992;305:20-2.
21) Mantzanis GJ, Stakianakis M, Archavlis E, et al. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis. Am J Gastroenterol 2004;99:1122-8.
22) Sood A, Kaushal V, Midha V, Bhatia KL, Sood N, Malhotra V. The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis. J Gastroenterol 2002;37:270-4.
23) Sood A, Midha V, Sood N, Avasthi G. Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis. Indian J Gastroenterol 2003;22:79-81.

 

書誌情報